Lydia Wilson, BS

Dana-Farber Cancer Institute
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• Paper 72 - GENOMIC EVOLUTION OF RESISTANCE IN GASTROINTESTINAL STROMAL TUMOR: KIT AP/AL MUTATIONS ARE A KEY MECHANISM OF KINASE-INHIBITOR ESCAPE

  Saturday, November 4, 2023
  11:30 AM – 1:00 PM